Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8617595 | NODEN PHARMA | Galenic formulations of organic compounds |
Feb, 2026
(2 years from now) | |
US8617595
(Pediatric) | NODEN PHARMA | Galenic formulations of organic compounds |
Aug, 2026
(3 years from now) |
Market Authorisation Date: 05 March, 2007
Treatment: NA
Dosage: TABLET;ORAL
7
United States
3
Russia
3
Peru
3
European Union
2
Australia
2
Malaysia
2
Korea, Republic of
2
China
2
Japan
1
South Africa
1
Mexico
1
Morocco
1
Norway
1
Singapore
1
Argentina
1
Brazil
1
Spain
1
Taiwan, Province of China
1
Ecuador
1
Canada
1
Tunisia
1
New Zealand
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic